Shot Kits & Free Shipping
We’re gifting CBD, get a surprise gift with any order. Plus Free shipping on orders over $99 ( US ground only ). SHOP NOW!

Isodiol International Inc Announces Retail Distribution of Pot-O-Coffee

April 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the product placement of Pot-O-Coffee and Pot-O-Tea in select Winn-Dixie stores throughout the East Coast.

With the past acquisition of Culinary Coffee Roasters, along with there pre-existing shelf space in leading grocers such as Winn-Dixie, Publix, and IGAs, Isodiol can now capitalize on tremendous distribution opportunities through mainstream retail outlets. These new distribution channels take Isodiol’s successful coffee and tea brand into a mainstream retail. Consumers will now be availed to the company’s wellness products that contain Isodiol’s proprietary hemp blends.

“With consumers hyper-sensitive to their health and wellness and wanting enhanced access to premium food and beverages, that not only taste good, but are good for you, we are able to combine both in our Pot-O-Coffee and Pot-O-Tea product lines,” said Marcos Agramont, CEO of Isodiol. “Now our health and wellness products can be accessed readily by consumers through mainstream sales channels and showcasing them alongside more traditional brands dramatically accelerates our value for both shareholders and consumers,” said Agramont.

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.

is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

ON BEHALF OF THE BOARD

“Marcos Agramont” CEO & Director

INVESTOR RELATIONS:

Ir@isodiol.com

Isodiol.com

COMPANY MEDIA :

Isodiol.com
Iso-sport.com
Potocoffee.coffee
BeTru Wellness
C3 Global Biosciences

Join Us On Facebook: https://www.facebook.com/Isodiol/
Twitter: @isodiol

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.